Feb 24, 2026 10:17AM
Dec 16, 2025 04:06PM
Dec 16, 2025 04:05PM
Nov 9, 2025 06:07PM
Nov 9, 2025 06:07PM
Nov 3, 2025 10:01AM
Nov 3, 2025 08:00AM Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta
Aug 6, 2025 04:05PM
Aug 6, 2025 08:06AM
Aug 6, 2025 08:05AM
Jul 31, 2025 08:06AM
Jul 31, 2025 08:05AM
May 7, 2025 04:05PM
Mar 21, 2025 07:10AM Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Mar 13, 2025 08:05AM
Feb 26, 2025 04:05PM
Dec 12, 2024 04:07PM
Dec 12, 2024 04:05PM
Nov 18, 2024 09:15PM
Nov 18, 2024 04:06PM
Nov 18, 2024 04:05PM Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency
Oct 31, 2024 04:05PM
Sep 4, 2024 08:30AM
Aug 20, 2024 06:45AM
Aug 1, 2024 04:02PM
Jun 26, 2024 08:05AM
Jun 26, 2024 08:05AM
Jun 5, 2024 02:37PM Vir Biotechnology (VIR) PT Raised to $15 at Morgan Stanley
Jul 5, 2023 07:18PM
Mar 24, 2023 01:18AM
Nov 16, 2022 08:30AM
Nov 16, 2022 08:30AM
Nov 3, 2022 04:03PM
Nov 3, 2022 04:03PM
Aug 23, 2022 07:30PM Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results
Aug 9, 2022 04:02PM
Aug 9, 2022 04:02PM
May 6, 2022 06:47AM
May 5, 2022 04:07PM
May 5, 2022 04:07PM
Apr 5, 2022 05:37PM
Apr 5, 2022 01:56PM Vir Biotechnology Inc. (VIR) Falls as FDA Says Sotrovimab no longer authorized to treat COVID-19 in any U.S. region
Mar 28, 2022 09:15AM
Mar 28, 2022 06:57AM
Mar 28, 2022 06:57AM
Mar 25, 2022 04:05PM
Mar 25, 2022 04:04PM
Mar 25, 2022 04:04PM
Mar 25, 2022 03:57PM UPDATE: Vir Biotechnology Inc. (VIR) Falls to Low, FDA updates Sotrovimab emergency use authorization
Feb 24, 2022 04:03PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All